Axogen, Inc.
AXGN· Nasdaq
AXGNAxogen, Inc.
Filed Mar 5, 2024 · 10-K · 65 days after period end · 0000805928-24-000028
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 |
|---|---|---|---|---|
| Revenue | $42.92M | $36.16M | $31.54M | $32.50M |
| Net Income | -$3.89M | -$5.42M | -$5.29M | -$6.01M |
| EPS Diluted | — | — |
Axogen, Inc. · CIK 805928 · Engraved from SEC EDGAR
| — |
| -$0.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2023 · filed Mar 5, 2024 · 65 d after period end
